PDA

View Full Version : Medical Articles and Abstracts


Pages : 1 2 3 [4]

  1. Blood management after bilateral total knee arthroplasty
  2. Bacterial reduction by cell salvage washing and leukocyte depletion filtration
  3. A comparison of red cell recovery between two different methods of red cell washing
  4. blood salvage during cesarean delivery in a patient with beta thalassemia intermedia
  5. Intraoperative Cell Salvage With Autotransfusion In Patients Undergoing Radical Retro
  6. Study of five cell salvage machines in coronary artery surgery
  7. A meta-analysis of the effectiveness of cell salvage to minimize perioperative transf
  8. Impact of red cell salvage on transfusion requirements during elective AAA
  9. Cell salvage for minimising perioperative allogeneic blood transfusion
  10. preoperative antiplatelet/anticoagulant prophylaxis on postoperative blood loss in CV
  11. Surgery without blood
  12. The CRIT Study: Anemia and blood transfusion in the critically ill
  13. A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement..
  14. Cell salvage for minimising perioperative allogeneic blood transfusion
  15. Quantifying risk of transfusion in children undergoing spine surgery.
  16. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion total joint
  17. Autotransfusion of shed mediastinal blood: a risk factor for mediastinitis after CABG
  18. [Intensive care patients need blood transfusion--with limits. Risks versus benefits
  19. RBC in Liver Transplantation: influence/outcome, predict/requirements, reducing
  20. Efficacy of intraoperative blood collection and reinfusion in revision total hip
  21. [Modern management of bleeding disorders and haemorrhage in otorhinolaryngology]
  22. Blood exposures and hepatitis C virus infections among emergency responders
  23. [Evidence-based management of chemotherapy related thrombocytopenia]
  24. Factors involved in gastrointestinal bleeding in advanced cancer patients [at home]
  25. Stents versus balloon angioplasty in non-acute coronary artery disease
  26. Does manual removal of the placenta affect operative blood loss during cesarean?
  27. Lovenox and retroperitoneal bleed
  28. Hemodialysis - Recombinant EPO therapy increases erythrocyte expression
  29. Online Presentation - Challange of Transfusion Alternatives - Actual and Prospective
  30. Pharmacotherapy of essential thrombocythaemia: economic considerations
  31. Coagulation monitoring and management of anticoagulation during cardiac assist device
  32. An Improved Definition of Immune Heparin-Induced Thrombocytopenia
  33. Oral vs Intravenous Vitamin K1 in Patients With Excessive Anticoagulation
  34. Markers of Coagulation and Angiogenesis in Cancer-Associated Venous Thromboembolism
  35. Defective RNA ribose synthesis in fibroblasts from patients with TRMA
  36. Recombinant humanized anti-IL-2 receptor antibody response in aplastic anemia
  37. Quantification of PRV-1 mRNA distinguishes PV secondary erythrocytosis
  38. New JAMA - Anemia and Heart Failure
  39. Volume 1 Number 11 November SABM Abstracts 003
  40. Quality of intraoperative autologous blood withdrawal used for retransfusion/ CABG
  41. Blood conservation strategies in Jehovah's Witness patient
  42. A method of blood conservation in Jehovah's witnesses
  43. impact of standard fluid management on the effectiveness of ANH in AAA
  44. Are tourniquets and drains really required in primary total knee?
  45. Anaphylactic transfusion reactions
  46. Risks of transfusion-transmitted infections: 2003
  47. Erythropoietin to treat head and neck cancer patients with anaemia
  48. Occam's razor; anaemia and orthostatic hypotension
  49. Hemoglobin F in primary myelofibrosis and in myelodysplasia
  50. Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis
  51. Duration/morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children
  52. Pharmacoeconomic considerations in the health system management of anaemia in patient
  53. Blood Use in Patients Undergoing Coronary Artery Bypass Surgery
  54. Emerging Infections, Transfusion Safety, and Epidemiology
  55. Transmission of West Nile Virus through Blood Transfusion in the United States - 2000
  56. A comparison of bleeding and transfusion in CABG & OPCAB
  57. Perioperative Anemia Requires Careful Evaluation and Treatment
  58. Anemia Not Directly Linked to Mortality After Acute MI
  59. Untreated Anemia Associated/increased Risk Of Mortality/morbidity
  60. Monitoring blood transfusion in patients undergoing coronary artery bypass grafting:
  61. Antiapoptotic effect of coagulation factor VIIa
  62. Detection of West Nile Virus in Blood Donations --- United States, 2003
  63. Computerized quality assurance of decisions to transfuse blood to the critically ill
  64. etiology and the effect of immunosuppressive therapy on erythropoiesis
  65. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based
  66. Suboptimal Erythropoietic Response to Hypoxemia in Idiopathic Pulmonary Fibrosis
  67. Anemia and Blood Transfusion in Trauma Patients Admitted to the Intensive Care Unit
  68. Lupus anticoagulants in children
  69. Inherited platelet disorders
  70. Long-term Use of Hydroxyurea for Sickle Cell Anemia—Reply
  71. Long-term Use of Hydroxyurea for Sickle Cell Anemia
  72. The Effects of EPO Given Immediately After Delivery
  73. SABM Literature Abstracts - July 2003
  74. Allogeneic blood transfusion increases the risk of postoperative bacterial infection
  75. WBC-containing allogeneic blood transfusion and mortality
  76. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery
  77. Uses and sources of data on long-term survival after blood transfusion
  78. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion
  79. Use of off-pump and on-pump CABG strategies in current clinical practice - Outcomes
  80. The efficacy and safety of aprotinin for hemostasis during intracranial surgery
  81. The management of perioperative bleeding
  82. Identification of risk factors for allogenic transfusion in cardiac surgery
  83. Factors for prolonged length of stay after elective hepatectomy
  84. Effects of enoxaparin vs unfractionated heparin on bleeding in CABG
  85. Efficacy of a single, weekly dose of recombinant EPO in myelodysplastic syndromes
  86. Ethical and medicolegal considerations in the obstetric care of a Jehovah's Witness
  87. Acute normovolemic hemodilution combined with inhibition of fibrinolysis and Cell Sav
  88. Anemia and erythropoietin in critically ill patients
  89. Influence of Allogeneic Blood Transfusion on Clinical Outcome during Radiotherapy
  90. Severe immune haemolysis in a group A recipient of a group O red blood cell unit
  91. Patient safety and blood transfusion: New solutions
  92. Transmission of HIV Type 1 through Blood Transfusion from an Antibody-Negative/p24
  93. Infectious risks of blood transfusion
  94. Fatal west nile virus meningoencephalitis associated / blood transfusion CV Surgery
  95. Myocardial ischaemia precipitated by acute normovolaemic haemodilution
  96. Influence of transfusions on perioperative and long-term outcome
  97. Peri-operative use of EPO
  98. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood trans
  99. Blood conservation in primary total hip arthroplasty
  100. Rising blood prices prompt hospitals to find cost-effective alternatives
  101. Attachment Pediatric Abstracts - August 2003
  102. Diamond-Blackfan anaemia response to cyclosporin-A therapy six years after diagnosis
  103. Estimated risk of transmission of the West Nile virus through blood
  104. West Nile virus infection transmitted by blood transfusion
  105. West Nile virus in blood: stability, distribution, and susceptibility PEN110
  106. West Nile virus and the safety of plasma derivatives
  107. Haemoglobin concentration and prognosis in new cases of heart failure
  108. Open versus laparoscopic splenectomy for idiopathic thrombocytopenic purpura
  109. Aortic Stenosis, von Willebrand Factor, and Bleeding
  110. Acquired von Willebrand Syndrome in Aortic Stenosis
  111. Valproate induces reversible factor XIII deficiency with risk of perioperative bleed
  112. Erythropoietin Given Immediately After Delivery to Women With Anaemia
  113. Anemia, Blood Transfusion, and Erythropoietin in the Critically Ill
  114. Haemoglobin concentration and prognosis in new cases of heart failure
  115. Thrombopoietin concentrations in peripheral blood
  116. Red Cell Transfusion "Trigger": A Review
  117. Correlation Between Perioperative Blood Transfusion and Prognosis of Patients
  118. Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation .....
  119. Platelet activation is increased in peripheral arterial disease
  120. Pediatric Abstracts - May 2003
  121. Pediatric Abstracts - July 2003
  122. Emergency Management of Hemorrhagic Complications
  123. Gastroenterology - helicobacter pylori and von Willebrand - induce platelet ag
  124. Complementary role / limitations of hepatitis C virus antibody and nucleic acid tests
  125. Acute thrombocytopenia associated with eptifibatide therapy
  126. Preoperative administration of epoetin alfa to reduce transfusion requirements in TJ
  127. Reduction of transfusion rates in the surgical correction of sagittal synostosis
  128. acute normovolemic hemodilution to minimize allogeneic blood transfusion liver resect
  129. Transfusion Requirements...hepatectomy..living donor
  130. Acute normovolemic hemodilution in urologic surgery
  131. Effect of aprotinin on transfusion requirements in pediatric orthotopic liver transpl
  132. Off-pump redo coronary artery bypass grafting: technical aspects and early results
  133. Recombinant Factor VIIa for the Management of Pediatric Coagulopathic Diseases
  134. Oxygen Therapeutics in Trauma and Surgery
  135. The Risk of Death for Jehovah's Witnesses after Major Trauma
  136. Resuscitation/Hemoglobin-Based Oxygen Carrier/Uncontrolled Periop Hemorrhage
  137. Allogeneic Blood Transfusion Increases the Risk of Postoperative Bacterial Infection
  138. Blood Transfusion, Independent of Shock Severity Associated/Worse Outcome in Trauma
  139. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platele
  140. Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8
  141. [Pernicious anemia and malignancy]
  142. Late-onset X-linked sideroblastic anemia following hemodialysis
  143. Differences in the perception of blood transfusion risk between laypeople and MDs
  144. Prevalence of transfusion-transmissible viral infections in first-time US donors Prevalence of tr
  145. Frequency of HBV DNA detection in US blood donors testing positive for...anti-HBc
  146. Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical
  147. Thrombopoietin increases platelet adhesion under flow and decreases rolling
  148. Aprotinin restores the adhesive capacity of dysfunctional platelets
  149. Pathologic Quiz Case: A 2-Year-Old Boy With a Hereditary Bleeding Disorder
  150. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic
  151. Potential new therapeutics for Waldenstrom's macroglobulinemia - Thalidomide
  152. Novel therapies in multiple myeloma - CC-5013 and bortezomib
  153. Effect of a National Disaster on Blood Supply and Safety
  154. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia
  155. Recovery from refractory ITP in three patients treated with etanercept
  156. Pharmacologic Tools for Blood Avoidance in Cadiac Surgery
  157. Blood Avoidance Mechanicals for Cadiac Surgery
  158. Blood Avoidance Algorithm for Cadiac Surgery
  159. Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies
  160. New Guidelines for Occupational Exposure to Bloodborne Viruses
  161. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood
  162. L-arginine, the Substrate for NO, Is...Low in Acute Vasoocclusive Sickle C Crisis
  163. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
  164. Perioperative Management of Patients Receiving Oral Anticoagulants
  165. Prevention and Control of Iron Deficiency Anemia Amongst Young Children
  166. The Outpatient Bleeding Risk Index
  167. May Pediatric Abstracts
  168. The harmonic scalpel and surgery of the thyroid gland
  169. Off-label use of recombinant factor VIIa in patients following bone marrow transplant
  170. The evidence behind inhibitor treatment with recombinant factor VIIa
  171. Recombinant factor VIIa to treat coagulation disturbances in pediatric patients
  172. Recombinant factor VIIa in children with inherited platelet function disorders
  173. Future generations of red blood cell substitutes (Chang - McGill)
  174. Benefit and risk perceptions in transfusion medicine: blood and blood substitutes
  175. Intraoperative Detection of Traumatic Coagulopathy... Activated Coagulation Time
  176. DDAVP normalized the bleeding time... congenital platelet TxA2 receptor
  177. Emerging infectious disease issues in blood safety
  178. Rethinking blood shield statutes
  179. Transfusion of blood components and postoperative infection in cardiac surgery
  180. Association of bacterial infection and red blood cell transfusion after CABS
  181. Blood transfusions correlate with infections in trauma patients
  182. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates
  183. Intraoperative Detection of Traumatic Coagulopathy Using the Activated Coagulation Ti
  184. Future generations of red blood cell substitutes
  185. Current status of blood substitute research: towards a new paradigm
  186. Benefit and risk perceptions in transfusion medicine: blood and blood substitutes
  187. SARS- Travelers from Canada
  188. Early primary immune response against erythrocytes: a case report
  189. Multivariate predictors of blood product use in cardiac surgery
  190. Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction
  191. Seven Ways to Control Postpartum Hemorrhage
  192. Serious Hazards of Transfusion (SHOT) 99-00
  193. Serious Hazards of Transfusion SHOT - 98-99
  194. Non-Infectious Serious Hazards of Transfusion
  195. Deleterious Effects of Blood Transfusions
  196. BMJ articles of interest.
  197. Pediatric Abstracts - April 2003
  198. Bloodless medicine and surgery in the OR and beyond
  199. RBC transfusion following the transfusion requirements in critical care
  200. Pediatric Abstracts Update February 03
  201. Influence of Erythrocyte Concentrate Storage Time on Postsurgical Morbidity
  202. Clinical Use Of Blood 'update In Anesthesia' Issue 14, 2002
  203. Sars
  204. Blood Transfusion - Length of Stay and Increased Charges
  205. Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia
  206. A new approach for the prevention and treatment of nutritional anemias